Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 2/2019

01-06-2019 | Case Report

Acinar Cell Carcinoma in the Background of Chronic Calcific Pancreatitis

Authors: Santhosh Anand, Sandip Chandrasekar, Biju Pottakkat, Meyyappa Devan Rajagopal, Bhawana Badhe

Published in: Journal of Gastrointestinal Cancer | Issue 2/2019

Login to get access

Excerpt

Acinar cell carcinoma (ACC) is a rare malignancy of pancreas. It represents around 1% of pancreatic exocrine tumors. Chronic pancreatitis is a predisposing factor for pancreatic adenocarcinoma (PAC). Locally advanced pancreatic tumors often require multivisceral resection. The present report describes a rare combination of ACC in a patient with chronic calcific pancreatitis (CCP). …
Literature
1.
Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas: a clinicopathological study of 28 cases. Am J Surg Pathol. 1992;16:815–37.CrossRefPubMed
2.
Burns WA, Matthews MJ, Hamosh M, Weide GV, Blum R, Johnson FB. Lipase-secreting acinar cell carcinoma of the pancreas with polyarthropathy. Cancer. 1974;33:1002–9.CrossRefPubMed
3.
Aqel B, Scolapio J, Nguyen J, Krishna M, Raimondo M. Recurrent pancreatitis due to cystic pancreatic tumor: a rare presentation of acinar cell carcinoma. JOP (online). 2004;5(3):151–4.
4.
Zahra Kebir F, Lahmar A, Arfa N, Manai S, El Ouaer MA, Bouraoui S, et al. Acinar cell carcinoma of the pancreas in young patient with chronic pancreatitis. Hepato Biliary Pancreac Dis Int. 2010;9:103–6.
5.
La Rosa S, Sessa F, Capella C. Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology. Front Med (Lausanne). 2015;2:41.
6.
Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1–7.CrossRefPubMed
7.
Yamamoto T, Ohzato H, Fukunaga M, Imamura H, Furukawa H. JOP. 2012;13(1):87–90.PubMed
8.
Kobayashi S, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, et al. Acinar cell carcinoma of the pancreas successfully treated by en bloc resection and intraperitoneal chemotherapy for peritoneal relapse: a case report of a 15 year survivor. Pancreas. 2001;23(1):109–12.CrossRefPubMed
9.
Wisnoski NC, Townsend CM Jr, Nealon WH, Freeman JL, Riall TS. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. Surgery. 2008;144:141–8.CrossRefPubMed
Metadata
Title
Acinar Cell Carcinoma in the Background of Chronic Calcific Pancreatitis
Authors
Santhosh Anand
Sandip Chandrasekar
Biju Pottakkat
Meyyappa Devan Rajagopal
Bhawana Badhe
Publication date
01-06-2019
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-017-0003-1

Other articles of this Issue 2/2019

Journal of Gastrointestinal Cancer 2/2019 Go to the issue

Original Research

MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer

Case Report

Locally Recurrent Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Tumor Requiring Re-excision Including Portal Vein Resection

Brief Communication

Correlates, Trends, and Short-Term Outcomes of Venous Thromboembolism in Hospitalized Patients with Hepatocellular Carcinoma

Original Research

Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma

Case Report

Radiotherapy for Gastric Bleeding from Tumor Invasion of Recurrent Colon Cancer with Liver Metastasis After Resection

Original Research

Clinical Impact of PI3K/BRAF Mutations in RAS Wild Metastatic Colorectal Cancer: Meta-analysis Results
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits